Figure 2.
The effect of differential PCGF1 expression levels on the prognosis of patients with glioma. (A-C) Kaplan-Meier curves of OS, PFI, and DSS between the PCGF1-high and -low expression cohorts. (D-I) Analysis of OS in 1p/19q non-codeletion, G3 and G4, age ≤60 years, male, female and wildtype IDH status between the PCGF1-high and -low expression cohorts. OS, overall survival; PFI, progression-free interval; DSS, disease specific survival; IDH, isocitrate dehydrogenase; WT, wildtype.